A Phase I Study of Hetrombopag Olamine in Healthy Adult Volunteers
Completed
Jiangsu HengRui Medicine Co., Ltd.
Phase 1
Hetrombopag Olamine made by Jiangsu Hengrui Medicine co Ltd. has shown an effect of
increasing platelet count in animal and human. This study is designed in dose escalation
fashion to evaluate safety, pharmacokinetics and efficacy of Hetrombopag Olamine.
A Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients
Unknown status
Jiangsu HengRui Medicine Co., Ltd.
Phase 1
The purpose of this study is to obtain information on efficacy, safety and Pharmacokinetics
(PK)/Pharmacodynamics (PD) of Hetrombopag over 14 days in Chinese patients with chronic ITP.
Effect of a High-fat Meal on the Pharmacokinetics of Hetrombopag and Mass Balance Study in Healthy Subjects
Completed
Jiangsu HengRui Medicine Co., Ltd.
Phase 1
This open-label, randomized, two-period, two-treatment (single doses of 7.5 mg hetrombopag
fasted or fed), crossover study was conducted to evaluate the effect of a high-fat meal on
the pharmacokinetics of hetrombopag and mass balance study in 12 healthy subjects.
Safety and Efficacy Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients
Unknown status
Jiangsu HengRui Medicine Co., Ltd.
Phase 1
This study evaluates the safety and efficacy of 6 weeks dosing Hetrombopag Olamine in Chronic
Idiopathic Thrombocytopenic Purpura Patients. All of the subjects in this study receive
Hetrombopag.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
